About
Physician-turned-investor in Munich, Peter Neubeck leverages medical training and an insistence on good data over hype to mentor early-stage academic biotech and bridge German-speaking and pan‑European ecosystems.
Contact· self-published, not guessed
Invests in
AI & Machine LearningBiotechHealthtechMedical DevicesRobotics
Experience
- Kurma PartnersPartnercurrent2019 — presentMunich Area, Germany
- Kurma PartnersAdvisor2017 — 2018
- ARMGO PharmaMember Board Of Directorscurrent2021 — present
- MedLumics, S.L.Member Board Of Directorscurrent2020 — present
- Corteria PharmaceuticalsMember Board Of Directorscurrent2021 — present
- Synendos Therapeutics AGMember Board Of Directorscurrent2020 — present
- Tacalyx GmbHMember Board Of Directorscurrent2019 — present
- Emergence TherapeuticsChair of the Board of Directors2023
- Emergence TherapeuticsMember of the Board of Directors2019 — 2022
- EvotecEVP ID Strategy2018
- ExB HealthAdvisor2016 — 2018München
- Morphochem AGChief Business Officer2017 — 2018Munich Area, Germany
- Spepharm AGChief Medical Officer2016 — 2017Luzern
- TVM CapitalVenture Partner2012 — 2015München
- TVM CapitalPrincipal2008 — 2012
- Aspireo PharmaceuticalsChief Business Officer2012 — 2015
- Aspireo PharmaceuticalsBoard member2011 — 2015
- Novartis Pharma AGDirector - Project Leader2006 — 2008
- Novartis Pharma AGManager Disease Area Strategy2005 — 2006
- McKinsey & CompanyAssociate2003 — 2005
- Beth Israel Deaconess Medical CenterResident / Senior Resident in Internal Medicine2001 — 2002
- Cleveland ClinicResident in Internal Medicine2000 — 2001
- Ludwig-Maximilians-Universität MünchenIntern / Resident in Neurology1998 — 2000
Skills & more
Licensing6Drug Development23Mergers4Business Development15Project Management4Venture Capital38Biotechnology10Clinical Development6Deal Execution2Deal Sourcing2Business Strategy5Due Diligence9
+12 more
NeurologyStrategyMergers & AcquisitionsExecutive ManagementEntrepreneurshipPharmaceutical IndustryCorporate DevelopmentM&A experienceLeadershipPrivate EquityCommercializationCorporate FinanceLanguages English · French · German · Japanese
From Peter's professional profile.
Colleagues at Kurma Partners
Alain Horvais
Partner at Kurma Partners
Amanda Gett
Partner at Kurma Partners
Anna Tchorzewska
Associate at Kurma Partners
Benjamin Belot
Partner at Kurma Partners
Cyril Bedran
Directeur Financier at Kurma Partners
Daniel Parera
Partner Germany at Kurma Partners
Fatima Boubnad
Assistante de gestion at Kurma Partners
Florence de Coorebyter
Associate at Kurma Partners
Frequently asked questions
- Who is Peter Neubeck?
- Physician-turned-investor in Munich, Peter Neubeck leverages medical training and an insistence on good data over hype to mentor early-stage academic biotech and bridge German-speaking and pan‑European ecosystems.
- Where does Peter Neubeck work?
- Peter Neubeck is Partner at Kurma Partners.
- What does Peter Neubeck invest in?
- Peter Neubeck invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices, Robotics.
- Where did Peter Neubeck go to school?
- Peter Neubeck studied at INSEAD (MBA); Ludwig-Maximilians-Universität München (MD, Medicine); Ludwig-Maximilians-Universität München (Doctor of Medicine - MD).
Same school
Also attended INSEAD1,029
Alexandre ProtCo-founder & CEO of QontoSteve AnaviCo-founder & President of QontoPatrick ClaessenPartner at Cottonwood Technology FundChris BischoffInvestment Team at General CatalystJan HammerInvestor at Index VenturesSandra SchwarzerInvestor at Index Ventures
+ 1,023 more
Also attended Ludwig-Maximilians-Universität München174
Celine XiaoInvestor at DN CapitalFriedrich von WulffenPrincipal at Burda Principal InvestmentsElçinTalent Team at Hummingbird VenturesLaura WeigertSenior Associate at Marlin Equity PartnersToby TriebelPartner at FinTech CollectiveGabriel MatuschkaPartner at Fly Ventures
+ 168 more
Shared employers
Also worked at MedLumics, S.L.9
Josep Ll. SanfeliuCo-founder and managing partner at Asabys PartnersSylvain SachotPartner at Asabys PartnersGuillem MasferrerPartner at Asabys PartnersJoël Jean-MairetManaging Partner at Ysios CapitalDiego BragugliaManaging Partner at VI PartnersPablo CironiManaging Director at Criteria Bio Ventures
+ 3 more
Also worked at Synendos Therapeutics AG1
Also worked at Evotec5
Also worked at Novartis Pharma AG164
Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures
+ 158 more





















.jpg)
























